Sort
40,608 grants matching “prostate cancer”
Targeting CD133 for imaging and therapy in prostate cancer
$355,706Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2021 · CA
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma
$355,706Nicholas K Foreman · University Of Colorado Denver · R01 · FY2020 · CA
Role of JMJD1A modifications in castration resistance of prostate cancer
$355,673Jianfei Qi · University Of Maryland Baltimore · R01 · FY2021 · CA
Southwest Oncology Group
$355,660Loyola University Chicago · U10 · FY2004 · CA
Investigating luminal plasticity in prostate tumorigenesis
$355,625Flaminia Talos · State University New York Stony Brook · R01 · FY2024 · CA
Investigating luminal plasticity in prostate tumorigenesis
$355,625Flaminia Talos · State University New York Stony Brook · R01 · FY2025 · CA
Mechanisms regulating prostate epithelium maintenance and regeneration
$355,605Sabina Signoretti · Brigham And Women'S Hospital · R01 · FY2011 · DK
Determinants of prostate cancer sensitivity to PD-1 blockade
$355,574Lawrence Fong · University Of California, San Francisco · R01 · FY2019 · CA
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$355,543Richard B Silverman · Northwestern University · R01 · FY2024 · CA
Regulation of the PCa Metastatic Phenotype by the HSC Niche
$355,543Russell S Taichman · University Of Michigan At Ann Arbor · P01 · FY2018 · CA
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
$355,517Matthew Redinbo · Univ Of North Carolina Chapel Hill · R01 · FY2012 · AI
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
$355,517Matthew Redinbo · Univ Of North Carolina Chapel Hill · R01 · FY2011 · AI
Reduced Reactive Oxygen Species and Oxidative Phosphorylation in Arsenic-Induced Cancer Stem Cells
$355,512Fei Chen · State University New York Stony Brook · R01 · FY2021 · ES
The role of MCM8-9 in genomic instability of cancers
$355,500Anindya Dutta · University Of Virginia · R01 · FY2016 · CA
The role of MCM8-9 in genomic instability of cancers
$355,500Anindya Dutta · University Of Virginia · R01 · FY2017 · CA
The role of MCM8-9 in genomic instability of cancers
$355,500Anindya Dutta · University Of Virginia · R01 · FY2014 · CA
The role of MCM8-9 in genomic instability of cancers
$355,500Anindya Dutta · University Of Virginia · R01 · FY2015 · CA
EARLY DETECTION, CHARACTERIZATION, AND MONITORING EFFICACY OF CHEMOTHERAPY IN PROSTATE CANCER USING HYPERPOLARIZED METABOLIC IMAGING
$355,497The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2012 · Department of Defense
PROJECT 2: Understanding the role of TP53 in LMS development
$355,427David Thomas · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors
$355,425Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2022 · CA
Generation and Dissemination of Enhanced AI/ML-ready Prostate Cancer Imaging Datasets for Public Use
$355,417Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2023 · EB
Administration Core
$355,417Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2023 · EB
Cancer Epidemiology
$355,369Israel David Goldman · Albert Einstein College Of Medicine, Inc · P30 · FY2016 · CA
Molecular basis for the impact of sex on brain tumorigenesis
$355,359Joshua B Rubin · Washington University · R01 · FY2024 · CA
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
$355,348Bertal H. Aktas · Brigham And Women'S Hospital · R01 · FY2015 · CA